STUB1 and therapy-related myeloid neoplasm: Unfortunately, the small number of patients does not allow definitive conclusions and underlines the need to extend the study of the role of CHIP to larger cohorts of patients who develop t-MN following treatment with chemo- and/or radio-therapy.